X hits on this document

615 views

0 shares

0 downloads

0 comments

45 / 147

needed subsequent technical assistance to switch patients from other atypical antipsychotics to

Risperdal.

152.

Janssen

also

worked

with

Omnicare

to

illegally

solicit

PALs

from

physicians

authorizing blanket switches to Risperdal. Janssen's actions in furtherance of this conspiracy

included:

  • Making false statements to Omnicare front line pharmacy personnel as to the reason for the switching. Janssen made false representations to Omnicare pharmacy staff, through materials prepared uniquely for Omnicare staff, through "kickoff' and other meetings designed to maximize the wholesale switching, and through making themselves available for technical consultations. These false representations included:

    • o

      That the switch to Risperdal was financially advantageous to the government and private insurers, when this was almost never the case.

    • o

      That Risperdal was clinically the most appropriate antipsychotic, when frequently this, too, was not the case.

  • Makingfalse statements to physicians as to the reasons for the switching. Janssen made its marketing personnel available at Omnicare-serviced nursing homes to work with Omnicare consultant pharmacists to convince physicians to sign PALs authorizing wholesale switches.

Failing to disclose kickbacks and other financial interests to physicians in helping

Omnicare solicit PALs. kickbacks to Omnicare medications.

Janssen did not disclose to for switching certain types

physicians that it of medications

was providing to "preferred"

  • Requiring Omnicare to develop computerized electronic capability to accurately track levels ofparticipation in the illegal PAL solicitation program by site and by prescribing clinician.

  • Rewarding Omnicare for the proportion of patients switched to Risperdal via illegal switching payments based in part on the success of the switching scheme.

153.

Janssen knew, intended, or reasonably should have known and foreseen that the

Market Share Agreement would induce Omnicare to engage in unauthorized medication

substitution, replacing the independent medical jndgment of a patient's physician or psychiatrist

with that of Omnicare pharmacists, consulting pharmacists, and other Omnicare employees, by

41

Document info
Document views615
Page views615
Page last viewedMon Jan 16 21:54:19 UTC 2017
Pages147
Paragraphs7751
Words41508

Comments